CB Insights
Technology Market Intelligence
Technology Market Intelligence
Aptevo Therapeutics (Nasdaq: APVO) is a biotech company primarily focused on bringing oncology and hematology therapeutics to market. We leverage the ADAPTIR platform technology, a unique approach to cancer immunotherapy, to improve outcomes for canc...Show all
Company (Alive / Active)
Phone: 206-838-0500
2401 4th Avenue
Suite 1050
Seattle, 98121
Washington, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Cd123 binding proteins and related compositions and methods | Mar 22, 2018 | Jun 09, 2020 | Patent |
| Cd37 immunotherapeutics and uses thereof | Jul 25, 2006 | Jun 04, 2019 | Patent |
| Oncofetal antigen binding proteins and related compositions and methods | Jul 20, 2018 | Mar 26, 2019 | Patent |
| Cd3 binding polypeptides | Apr 18, 2013 | Feb 12, 2019 | Patent |
| B-cell reduction using cd37-specific and cd20-specific binding molecules | Mar 15, 2013 | Dec 04, 2018 | Patent |
